Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral bicarbonate and intravenous butylscopolamine to facilitate spontaneous delivery in induced labor
2024-511848-55-00Phase 3Authorised
- Sponsor
- Oslo University Hospital
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of hyoscine butylbromide and sodium bicarbonate in childbirth (4 arms), sponsored by Oslo University Hospital. Primary endpoint: Mode of delivery. Planned start Oct 2024; status: authorised.
02
Drugs
hyoscine butylbromidesodium bicarbonate
03
Conditions
childbirth
Beyond the preview
Go deeper on 2024-511848-55-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511848-55-00.